Dr. Lucas Scott Blanton, MD

Dr. Blanton practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Blanton's NPI, 1265519490, was assigned on November 1, 2006. Dr. Blanton graduated from UTMB Health in 2005. Dr. Blanton's Texas license number on file is N7397.

Dr. Blanton's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Blanton's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blanton practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Blanton's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Blanton is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Blanton's licenses on file in 2 states: Texas and South Carolina.

Dmand AI lists acute skin infection, hiv/aids, joint or bone infection and shingles among the conditions Dr. Blanton treats.

CMS data shows 301 Medicare services from Dr. Blanton across 7 procedure codes in 2024, for 129 Medicare patients. Medicare paid $21,692 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 129 Medicare patients who saw Dr. Blanton in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 31% are also on Medicaid. Their average risk score is 3.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blanton's median patient age at 63, with 37% women.

In 2024, Dr. Blanton wrote 2,268 Medicare Part D claims for 152 patients. 72% of them were for generic drugs. CMS names the drug for 1,965 of them, across 55 drugs with 11 or more claims each, at $1,918,834 in total drug cost. In 2023, CMS named 1,513 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Blanton for performance year 2024, reported as part of a group. Dr. Blanton accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 60 papers to Dr. Blanton, published from 2011 to 2025. 2016 was the busiest year, with 7. The most frequent topics are Rickettsia, Rickettsia Infections and Texas. Dr. Blanton has published most often in Am J Trop Med Hyg. Dr. Blanton's most frequent co-authors are Rahat Firoz Vohra, MD, Megan Anne Berman, MD and Maria Alejandra Caravedo Martinez, MD.

CMS Open Payments shows 3 general payments to Dr. Blanton from 2 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. ViiV Healthcare Company paid the most, $114.

Dmand AI lists 2 awards for Dr. Blanton, most recently CMS Stage 1 EHR in 2013.

Dr. Blanton graduated from UTMB Health in 2005.

Dr. Blanton is in network with 21 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.